Skip to main content
Caplight Logo









TYBR Health

TYBR Health

Private
Houston, TexasHealthcare & Life Scienceshttps://www.tybrhealth.com/

Last Round

Series A

Jul 21, 2026

Est. Valuation

$66M

Total Funding Raised

$39.69M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

TYBR Health is a medical device and regenerative medicine company that develops bioresorbable hydrogel solutions to improve post-operative recovery by protecting healing tissues and preventing internal scarring.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicehydrogelextracellular matrixECMadhesion preventionbioresorbableorthopaedic surgerytissue tetheringscar preventionregenerative medicinebiomaterialspost-surgical recoverysurgical barrieranti-adhesion barriersports medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TYBR Health Comparables

Compare TYBR Health with similar companies based on industry and business-model similarity.

TYBR Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Betatech Medical
77%
MAST Biosurgery AG
77%
Integra LifeSciences Holdings Corporation
77%

TYBR Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 21, 2026
SeedNov 26, 2025
SeedJan 31, 2025
AcceleratorMay 29, 2024
AcceleratorMar 29, 2022
Grant
Aug 11, 2021

Key People

Founding team and executive leadership

P. Alex Smith

Chief Technology Officer Co-founder

Founding Team

Tim Keane

Cofounder CEO

Founding Team

TYBR Health Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 21, 2026

    $30M round led by Mutual Capital Partners and Vensana Capital.

  • Jan 12, 2026

    Jeff Tyber appointed to the Board of Directors.

TYBR Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TYBR Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TYBR Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas
Employee Range15
Year Founded2020
Last FundingJul 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?